Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013/10/23 by Richard S. Legro, Silva Arslanian, Silva A. Arslanian +5 · 33 citations
Medicine · #Ovarian function and disorders #Menopause: Health Impacts and Treatments #Growth Hormone and Insulin-like Growth Factors
paper · pdf · doi:10.1210/jc.2013-2350
Abstract
OBJECTIVE: The aim was to formulate practice guidelines for the diagnosis and treatment of polycystic ovary syndrome (PCOS). PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer developed the guideline. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. Two systematic reviews were conducted to summarize supporting evidence. CONCLUSIONS: We suggest using the Rotterdam criteria for diagnosing PCOS (presence of two of the following criteria: androgen excess, ovulatory dysfunction, or polycystic ovaries). Establishing a diagnosis of PCOS is problematic in adolescents and menopausal women. Hyperandrogenism is central to the presentation in adolescents, whereas there is no consistent phenotype in postmenopausal women. Evaluation of women with PCOS should exclude alternate androgen-excess disorders and risk factors for endometrial cancer, mood disorders, obstructive sleep apnea, diabetes, and cardiovascular disease. Hormonal contraceptives are the first-line management for menstrual abnormalities and hirsutism/acne in PCOS. Clomiphene is currently the first-line therapy for infertility; metformin is beneficial for metabolic/glycemic abnormalities and for improving menstrual irregularities, but it has limited or no benefit in treating hirsutism, acne, or infertility. Hormonal contraceptives and metformin are the treatment options in adolescents with PCOS. The role of weight loss in improving PCOS status per se is uncertain, but lifestyle intervention is beneficial in overweight/obese patients for other health benefits. Thiazolidinediones have an unfavorable risk-benefit ratio overall, and statins require further study.
Citations
Cited by
- Effects of a ketogenic diet in overweight women with polycystic ovary syndrome
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
- Carbohydrate Intake Prior to Oral Glucose Tolerance Testing
- Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity
- Recurrent pregnancy loss
- Mapping burdens and inequalities of polycystic ovary syndrome in young females across 953 locations 1990–2040 with deep learning forecasts
- Knowledge, attitude and practice toward obesity and polycystic ovary syndrome among women of childbearing age with overweight or obesity
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Functional genomics of PCOS: from GWAS to molecular mechanisms. [europepmc]
- Poly Cystic Ovarian Syndrome: An Updated Overview. [europepmc]
- CLINICAL PRACTICE. Polycystic Ovary Syndrome. [europepmc]
- Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome. [europepmc]
- Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. [europepmc]
- Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis. [europepmc]
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. [europepmc]
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. [europepmc]
- Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association. [europepmc]
- Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Female Fertility. [europepmc]
- Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. [europepmc]
- Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). [europepmc]
- Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota. [europepmc]
- Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. [europepmc]
- Adolescent polycystic ovary syndrome according to the international evidence-based guideline. [europepmc]
- Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. [europepmc]
- Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. [europepmc]
- Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017. [europepmc]
- Diagnosis and Management of Infertility: A Review. [europepmc]
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome. [europepmc]
- Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature. [europepmc]
- Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism. [europepmc]
- ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. [europepmc]
- Current Guidelines for Diagnosing PCOS. [europepmc]
- The crucial role and mechanism of insulin resistance in metabolic disease. [europepmc]
Related